Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Cingulate Yönetim

Yönetim kriter kontrolleri 2/4

Cingulate's CEO is Shane Schaffer, appointed in Jan 2012, has a tenure of 12.75 years. total yearly compensation is $629.57K, comprised of 78.1% salary and 21.9% bonuses, including company stock and options. directly owns 0.008% of the company’s shares, worth $872.29. The average tenure of the management team and the board of directors is 6.8 years and 0.7 years respectively.

Anahtar bilgiler

Shane Schaffer

İcra Kurulu Başkanı

US$629.6k

Toplam tazminat

CEO maaş yüzdesi78.1%
CEO görev süresi12.8yrs
CEO sahipliği0.008%
Yönetim ortalama görev süresi6.8yrs
Yönetim Kurulu ortalama görev süresiless than a year

Son yönetim güncellemeleri

Recent updates

Here's Why We're A Bit Worried About Cingulate's (NASDAQ:CING) Cash Burn Situation

Aug 26
Here's Why We're A Bit Worried About Cingulate's (NASDAQ:CING) Cash Burn Situation

Cingulate Q2 GAAP EPS of -$0.36

Aug 11

Is Cingulate (NASDAQ:CING) In A Good Position To Deliver On Growth Plans?

Apr 04
Is Cingulate (NASDAQ:CING) In A Good Position To Deliver On Growth Plans?

CEO Tazminat Analizi

Shane Schaffer'un ücretlendirmesi Cingulate'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$19m

Mar 31 2024n/an/a

-US$23m

Dec 31 2023US$630kUS$492k

-US$24m

Sep 30 2023n/an/a

-US$21m

Jun 30 2023n/an/a

-US$19m

Mar 31 2023n/an/a

-US$17m

Dec 31 2022US$583kUS$475k

-US$18m

Sep 30 2022n/an/a

-US$16m

Jun 30 2022n/an/a

-US$27m

Mar 31 2022n/an/a

-US$24m

Dec 31 2021US$1mUS$475k

-US$21m

Sep 30 2021n/an/a

-US$19m

Jun 30 2021n/an/a

-US$5m

Mar 31 2021n/an/a

-US$6m

Dec 31 2020US$275kUS$275k

-US$7m

Tazminat ve Piyasa: Shane's total compensation ($USD629.57K) is about average for companies of similar size in the US market ($USD667.78K).

Tazminat ve Kazançlar: Shane's compensation has increased whilst the company is unprofitable.


CEO

Shane Schaffer (49 yo)

12.8yrs

Görev süresi

US$629,571

Tazminat

Dr. Shane J. Schaffer, PharmD, co-founded Cingulate Inc. in 2012 and since serves as its Chief Executive Officer and Chairman of the Board and served as its Principal Financial Officer since December 13, 2...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Shane Schaffer
CEO & Chairman of the Board12.8yrsUS$629.57k0.0079%
$ 872.3
Laurie Myers
Executive VP & COO6.5yrsUS$476.33k0%
$ 0
Matthew Brams
Executive VP & Chief Medical Officer6.8yrsUS$267.73k0.12%
$ 13.7k
Jennifer Callahan
Senior VPless than a yearVeri yokVeri yok
Raul Silva
Executive VP & Chief Science Officer6.8yrsVeri yokVeri yok
Thomas Dalton
Vice President of Investor & Public Relationsno dataVeri yokVeri yok

6.8yrs

Ortalama Görev Süresi

60yo

Ortalama Yaş

Deneyimli Yönetim: CING's management team is seasoned and experienced (6.8 years average tenure).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Shane Schaffer
CEO & Chairman of the Board12.8yrsUS$629.57k0.0079%
$ 872.3
John Roberts
Independent Directorless than a yearVeri yokVeri yok
Bryan Lawrence
Independent Directorless than a yearVeri yokVeri yok
Peter Werth
Director6.3yrsUS$47.94k0.0042%
$ 463.6
Jeffrey Newcorn
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Andrew Cutler
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Jeffrey S. Ervin
Independent Directorless than a yearVeri yokVeri yok
Ann Childress
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Brian Barash
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Laurence Greenhill
Member of Scientific Advisory Boardno dataVeri yokVeri yok
John Markowitz
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Dinohra Munoz-Silva
Member of Scientific Advisory Boardno dataVeri yokVeri yok

0.7yrs

Ortalama Görev Süresi

58yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: CING's board of directors are not considered experienced ( 0.7 years average tenure), which suggests a new board.